Immunoregulatory and effector activities in human cutaneous and mucosal Leishmaniasis: Understanding mechanisms of pathology

Drug Development Research

Volumn 72, Issue 6, 2011, Pages 430-436

  Dutra, Walderez O ^a,b,d   De Faria, Daniela Rodrigues ^a   MacHado, Paulo Roberto Lima ^c,d   Guimarães, Luiz Henrique ^c,d   Schriefer, Albert ^c,d   Carvalho, Edgar ^c,d   Gollob, Kenneth J ^b,d,e  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b SRI INTERNATIONAL   (United States)

^c FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^d Instituto Nacional de Ciência e Tecnologia Informação Pecuária   (Brazil)

^e Santa Casa Hospital   (Brazil)

Author keywords

human; immunoregulation; leishmaniasis; pathology

Indexed keywords

CYTOKINE; GRANZYME A;

ARTICLE; CONFOCAL LASER MICROSCOPY; CYTOKINE PRODUCTION; FLOW CYTOMETRY; HOST PARASITE INTERACTION; HUMAN; IMMUNOPATHOGENESIS; IMMUNOREGULATION; INFLAMMATORY INFILTRATE; LEISHMANIA BRAZILIENSIS; LEISHMANIASIS; SKIN LEISHMANIASIS;

EID: 80053046404     PISSN: 02724391     EISSN: 10982299     Source Type: Journal    
DOI: 10.1002/ddr.20449     Document Type: Article

References (27)

1. Amato VS, Andrade HF, Amato Neto V, Duarte MI,. 2003. Short report: persistence of tumor necrosis factor-alpha in situ after lesion healing in mucosal leishmaniasis. Am J Trop Med Hyg 68: 527-528. (Pubitemid 38240486)
2. Antonelli LR, Dutra WO, Almeida RP, Bacellar O, Gollob KJ,. 2004. Antigen specific correlations of cellular immune responses in human leishmaniasis suggests mechanisms for immunoregulation. Clin Exp Immunol 136: 341-348. (Pubitemid 38543455)
3. Antonelli LR, Dutra WO, Almeida RP, Bacellar O, Carvalho EM, Gollob KJ,. 2005. Activated inflammatory T cells correlate with lesion size in human cutaneous leishmaniasis. Immunol Lett 101: 226-230. (Pubitemid 41368083)
4. Bacellar O, Lessa H, Schriefer A, Machado P, Ribeiro de Jesus A, Dutra WO, Gollob KJ, Carvalho EM,. 2002. Up-regulation of Th1-type responses in mucosal leishmaniasis patients. Infect Immun 70: 6734-6740. (Pubitemid 35387904)
5. Bittar RC, Nogueira RS, Vieira-Goncalves R, Pinho-Ribeiro V, Mattos MS, Oliveira-Neto MP, Coutinho SG, Da-Cruz AM,. 2007. T-cell responses associated with resistance to Leishmania infection in individuals from endemic areas for Leishmania (Viannia) braziliensis. Mem Inst Oswaldo Cruz 102: 625-630. (Pubitemid 47367443)
6. Bittencourt AL, Barral A,. 1991. Evaluation of the histopathological classifications of American cutaneous and mucocutaneous leishmaniasis. Mem Inst Oswaldo Cruz 86: 51-56.
7. Bottrel RL, Dutra WO, Martins FA, Gontijo B, Carvalho E, Barral-Netto M, Barral A, Almeida RP, Mayrink W, Locksley R, et al. 2001. Flow cytometric determination of cellular sources and frequencies of key cytokine-producing lymphocytes directed against recombinant LACK and soluble-antigen in human cutaneous leishmaniasis. Infect Immun 69: 3232-3239. (Pubitemid 32332221)
8. Caceres-Dittmar G, Tapia FJ, Sanchez MA, Yamamura M, Uyemura K, Modlin RL, Bloom BR, Convit J,. 1993. Determination of the cytokine profile in American cutaneous leishmaniasis using the polymerase chain reaction. Clin Exp Immunol 91: 500-505. (Pubitemid 23074159)
9. Carvalho LP, Passos S, Bacellar O, Lessa M, Almeida RP, Magalhaes A, Dutra WO, Gollob KJ, Machado P, de Jesus AR,. 2007. Differential immune regulation of activated T cells between cutaneous and mucosal leishmaniasis as a model for pathogenesis. Parasite Immunol 29: 251-258. (Pubitemid 46596117)
10. Castellucci L, Menezes E, Oliveira J, Magalhaes A, Guimaraes LH, Lessa M, Ribeiro S, Reale J, Noronha EF, Wilson ME, et al. 2006. IL6-174 G/C promoter polymorphism influences susceptibility to mucosal but not localized cutaneous leishmaniasis in Brazil. J Infect Dis 194: 519-527. (Pubitemid 44162665)
11. Da-Cruz AM, Oliveira-Neto MP, Bertho AL, Mendes-Aguiar CO, Coutinho SG,. 2010. T cells specific to leishmania and other nonrelated microbial antigens can migrate to human leishmaniasis skin lesions. J Invest Dermatol 130: 1329-1336.
12. Faria DR, Gollob KJ, Barbosa Jr J, Schriefer A, Machado PR, Lessa H, Carvalho LP, Romano-Silva MA, de Jesus AR, Carvalho EM, et al. 2005. Decreased in situ expression of interleukin-10 receptor is correlated with the exacerbated inflammatory and cytotoxic responses observed in mucosal leishmaniasis. Infect Immun 73: 7853-7859. (Pubitemid 41740268)
13. + T cells expressing granzyme A is associated with lesion progression in human cutaneous leishmaniasis. Parasite Immunol 31: 432-439.
14. Gaze ST, Dutra WO, Lessa M, Lessa H, Guimaraes LH, Jesus AR, Carvalho LP, Machado P, Carvalho EM, Gollob KJ,. 2006. Mucosal leishmaniasis patients display an activated inflammatory T-cell phenotype associated with a nonbalanced monocyte population. Scand J Immunol 63: 70-78.
15. + memory T cells following-infection. Trends Parasitol 21: 347-350. (Pubitemid 40968130)
16. Gomes-Silva A, de Cassia Bittar R, Dos Santos Nogueira R, Amato VS, da Silva Mattos M, Oliveira-Neto MP, Coutinho SG, Da-Cruz AM,. 2007. Can interferon-gamma and interleukin-10 balance be associated with severity of human Leishmania (Viannia) braziliensis infection? Clin Exp Immunol 149: 440-444. (Pubitemid 47256154)
17. Lessa HA, Machado P, Lima F, Cruz AA, Bacellar O, Guerreiro J, Carvalho EM,. 2001. Successful treatment of refractory mucosal leishmaniasis with pentoxifylline plus antimony. Am J Trop Med Hyg 65: 87-89. (Pubitemid 32746963)
18. Lessa MM, Lessa HA, Castro TW, Oliveira A, Scherifer A, Machado P, Carvalho EM,. 2007. Mucosal leishmaniasis: epidemiological and clinical aspects. Braz J Otorhinolaryngol 73: 843-847.
19. Machado P, Kanitakis J, Almeida R, Chalon A, Araujo C, Carvalho EM,. 2002. Evidence of in situ cytotoxicity in American cutaneous leishmaniasis. Eur J Dermatol 12: 449-451. (Pubitemid 35205132)
20. Machado PR, Lessa H, Lessa M, Guimaraes LH, Bang H, Ho JL, Carvalho EM,. 2007. Oral pentoxifylline combined with pentavalent antimony: a randomized trial for mucosal leishmaniasis. Clin Infect Dis 44: 788-793. (Pubitemid 46365302)
21. Melby PC, Darnell BJ, Tryon VV,. 1993. Quantitative measurement of human cytokine gene expression by polymerase chain reaction. J Immunol Methods 159: 235-244.
22. Melby PC, Andrade-Narvaez FJ, Darnell BJ, Valencia-Pacheco G, Tryon VV, Palomo-Cetina A,. 1994. Increased expression of proinflammatory cytokines in chronic lesions of human cutaneous leishmaniasis. Infect Immun 62: 837-842. (Pubitemid 24065562)
23. Pirmez C, Cooper C, Paes-Oliveira M, Schubach A, Torigian VK, Modlin RL,. 1990. Immunologic responsiveness in American cutaneous leishmaniasis lesions. J Immunol 145: 3100-3104. (Pubitemid 20382586)
24. Pirmez C, Yamamura M, Uyemura K, Paes-Oliveira M, Conceicao-Silva F, Modlin RL,. 1993. Cytokine patterns in the pathogenesis of human leishmaniasis. J Clin Invest 91: 1390-1395. (Pubitemid 23127337)
25. Ramasawmy R, Menezes E, Magalhaes A, Oliveira J, Castellucci L, Almeida R, Rosa ME, Guimaraes LH, Lessa M, Noronha E, et al. 2010. The -2518bp promoter polymorphism at CCL2/MCP1 influences susceptibility to mucosal but not localized cutaneous leishmaniasis in Brazil. Infect Genet Evol 10: 607-613.
26. Salhi A, Rodrigues Jr V, Santoro F, Dessein H, Romano A, Castellano LR, Sertorio M, Rafati S, Chevillard C, Prata A, et al. 2008. Immunological and genetic evidence for a crucial role of IL-10 in cutaneous lesions in humans infected with Leishmania braziliensis. J Immunol 180: 6139-6148.
27. Schriefer A, Schriefer AL, Goes-Neto A, Guimaraes LH, Carvalho LP, Almeida RP, Machado PR, Lessa HA, de Jesus AR, Riley LW, et al. 2004. Multiclonal Leishmania braziliensis population structure and its clinical implication in a region of endemicity for American tegumentary leishmaniasis. Infect Immun 72: 508-514. (Pubitemid 38018212)